Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lexaria Bioscience Corp (NQ: LEXX ) 2.730 -0.030 (-1.09%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Lexaria Bioscience Corp < Previous 1 2 ... 5 6 7 8 9 10 11 12 13 ... 27 28 Next > Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes $2 Million Public Offering Consisting of Common Shares and Accompanying Warrants May 23, 2023 Via Investor Brand Network Lexaria Discovers that DehydraTECH-CBD Treatment in Hypertension Study HYPER-H21-4 Resulted in Reduction in Pro-Inflammatory Biomarkers May 23, 2023 Via ACCESSWIRE Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Dosing in Human Oral Nicotine Study, Hopes to Facilitate More Satisfying Experience with DehydraTECH(TM)-Processed Oral Nicotine May 22, 2023 Via Investor Brand Network Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Dosing in Human Oral Nicotine Study, Hopes to Facilitate More Satisfying Experience with DehydraTECH(TM)-Processed Oral Nicotine May 22, 2023 Via CannabisNewsWire 12 Health Care Stocks Moving In Friday's Pre-Market Session May 19, 2023 Via Benzinga Lexaria's Hormone Study Shows Significant Enhancement in Oral Estradiol Delivery May 18, 2023 Via ACCESSWIRE Lexaria Announces 2023 Annual Meeting Results May 10, 2023 Via ACCESSWIRE Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pivotal Milestones Concerning DehydraTECH(TM) Technology, Including IND Application Plans May 19, 2023 Via Investor Brand Network TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Study Demonstrates Significant Enhancement in Oral Estradiol Delivery May 18, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Study Shows Significant Improvements In Peak Bloodstream Estradiol Delivery Using Lexaria's DehydraTECH May 18, 2023 Lexaria Bioscience Corp (NASDAQ: LEXX) announces that its animal study HOR-A22-1 has been completed, showing significant enhancement in the oral delivery of the Via Benzinga Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off FDA IND Filing Process with Granted CRO Contract to California-Based InClin, Inc. May 16, 2023 Via Investor Brand Network Exposures Product Safety CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures $2M in Public Offering May 12, 2023 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures $2M in Public Offering May 12, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Completion of cGMP Manufacturing for Upcoming Clinical Trial May 11, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Product Safety CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Completion of cGMP Manufacturing for Upcoming Clinical Trial May 11, 2023 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property Product Safety Lexaria Bioscience Announces Closing of $2.0 Million Public Offering May 11, 2023 Via ACCESSWIRE cGMP Manufacturing Complete for Lexaria's Upcoming U.S. Phase 1b Hypertension Clinical Trial May 11, 2023 Via ACCESSWIRE CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of 2023 Annual Meeting May 10, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of 2023 Annual Meeting May 10, 2023 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property 12 Health Care Stocks Moving In Tuesday's Intraday Session May 09, 2023 Via Benzinga Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 09, 2023 Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. Via Benzinga Why Is Nikola (NKLA) Stock Down Today? May 09, 2023 Nikola (NKLA) stock is taking a beating on Tuesday after the company announced bad news alongside its latest earnings report. Via InvestorPlace Novavax Layoffs 2023: What to Know About the Latest NVAX Job Cuts May 09, 2023 Novavax (NVAX) layoffs are on the way as the vaccine maker revealed plans to cut a large portion of its workforce on Tuesday! Via InvestorPlace Why Is Lexaria Bioscience (LEXX) Stock Down 27% Today? May 09, 2023 Lexaria Bioscience (LEXX) stock is falling on Tuesday after the company revealed details about its public share offering. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 09, 2023 Via Benzinga Why ClearOne Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket May 09, 2023 Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) gained 74.2% to $0.2701 in pre-market trading after gaining around 7% on Monday. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday May 09, 2023 We're starting off the day with the biggest pre-market stock movers traders will want to keep in mind while trading on Tuesday! Via InvestorPlace Lexaria Bioscience Announces Pricing of $2.0 Million Public Offering May 08, 2023 Via ACCESSWIRE CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Dosing Completed on Human Clinical Nicotine Study May 08, 2023 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Dosing Completed on Human Clinical Nicotine Study May 08, 2023 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property < Previous 1 2 ... 5 6 7 8 9 10 11 12 13 ... 27 28 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.